Chemotherapy and Tyrosine Kinase Inhibitors in the last month of life in patients with metastatic lung cancer: A patient file study in the Netherlands

OBJECTIVE: Chemotherapy in the last month of life for patients with metastatic lung cancer is often considered as aggressive end‐of‐life care. Targeted therapy with Tyrosine Kinase Inhibitors (TKIs) is a relatively new treatment of which not much is known yet about use in the last month of life. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Mieras, Adinda, Becker‐Commissaris, Annemarie, Pasman, H. Roeline W., Dingemans, Anne‐Marie M. C., Kok, Edith V., Cornelissen, Robin, Jacobs, Wouter, van den Berg, Jan Willem, Welling, Alle, Bogaarts, Brigitte A. H. A., Pronk, Lemke, Onwuteaka‐Philipsen, Bregje D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285506/
https://www.ncbi.nlm.nih.gov/pubmed/31863609
http://dx.doi.org/10.1111/ecc.13210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285506/
https://www.ncbi.nlm.nih.gov/pubmed/31863609
http://dx.doi.org/10.1111/ecc.13210

Ejemplares similares